Johnson & Johnson (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021
Corporate Participants:
Christopher DelOrefice — Vice President of Investor Relations
Joseph J. Wolk — Executive Vice President and Chief Financial Officer
Paul Stoffels — Vice Chairman of the Executive Committee and Chief Scientific Officer
Alex Gorsky — Chairman, Board of Directors and Chief Executive Officer
Joaquin Duato — Vice Chairman of the Executive Committee
Analysts:
Chris Schott — J.P. Morgan — Analyst
Larry Biegelsen — Wells Fargo — Analyst
Joanne Wuensch — Citi — Analyst
Bob Hopkins — Bank of America Merrill Lynch — Analyst
Joshua Jennings — Cowen and Company — Analyst
Louise Chen — Cantor Fitzgerald — Analyst
Danielle Antalffy — SVB Leerink — Analyst
Matt Miksic — Credit Suisse — Analyst
Terence Flynn — Goldman Sachs — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
Listen On
